期刊文献+

JC病毒衣壳蛋白VP1多克隆抗体的制备 被引量:1

Preparation of JC virus capsid protein-VP1 polyclonal antibody
原文传递
导出
摘要 目的制备pET-32a(+)-VP1蛋白的多克隆抗体。方法用纯化后的VP1蛋白分4次免疫兔子,颈动脉插管法取血,制得多克隆抗体。结果用ELISA法和Western blot鉴定多克隆抗体的效价得1?320000。该抗体可以用Western blot法检测出59 kD左右的VP1蛋白。结论成功制备高效价的JC病毒衣壳蛋白VP1多克隆抗体。 Objective To preparate the pET-32a(+)-VP1 polyclonal antibody.Method Rabbits were immuned with purified VP1 four times.Polyclonal antibody was made by carotid artery intubation and withdrawing blood.Result The titer of polyclonal antibody was 1︰320000 detected by ELISA and Western blot.VP1 protein with the molecular weight at approximate 59 kD had been detected by Western blot.Conclusion The study successfully prepare JC virus capsid protein-VP1 polyclonal antibody with high titer.
出处 《中国微生态学杂志》 CAS CSCD 2010年第10期884-885,893,共3页 Chinese Journal of Microecology
基金 北京市科委资助项目(D0906003040291)
关键词 JC病毒 VP1蛋白 多克隆抗体 JC virus; VP1 protein; Polyclonal antibody;
  • 相关文献

参考文献8

  • 1白瑞玲,王勤英,成军,赵龙凤,毛羽.JC病毒衣壳蛋白VP1在大肠杆菌中的表达及纯化[J].医学研究杂志,2009,38(5):37-40. 被引量:1
  • 2AGOSTINI H T, YANAGIHARA R, VICTOR DAVIS,et al. Asian genotypes of JC virus in Native Americans and in a Pacific Island population: Markers of viral evolution and human migration[J]. PNAS USA, 1997,94: 14542-14546.
  • 3MAJOR E, AMEMIYA K, TORNATORE C S, et al. Pathogenesis and molecular biology of progressive muhifocal Leukoencephalopathy, the JC vires-induced demyelinating disease of the human brain [J]. Clin Mocrobiol Rev, 1992,5( 1 ) :49-73.
  • 4LIN Paul-yarm, FLING Chiung-yau, CHANG Fang-pei, et al. Prevalence and genotype identification of Human JC virus in colon cancer in Taiwan[ J]. J Med Virol,2008,80( 10 ) : 1828-1834.
  • 5LANDRYA M L, EIDA T, BANNYKHB S, et al. False negative PCR despite high levels of JC virus DNA in spinal fluid: Implications for diagnostic testing[J]. J Clin Virol,2008,43 ( 2 ) :247-249.
  • 6GASPAROVIC M L, GEE G V, ATWOOD W J, et al. Quantitative real-time PCR assay for detection of human polyomavirus infection [J]. J Virolog Methods,2006,135 ( 2 ) : 207 -213.
  • 7孙佳,李小兵,孔涛,许超,王照鹏,杨威,刘磊,王哲.牛抵抗素多克隆抗体的制备及ELISA检测方法的建立[J].中国畜牧兽医,2009,36(11):82-85. 被引量:2
  • 8付云洁,刘志国,武玉香.苏丹红Ⅰ多克隆抗体的制备研究[J].武汉工业学院学报,2009,28(2):1-4. 被引量:2

二级参考文献16

  • 1郭利军,王晶,申元英,王涛.三种免疫血清制备方法的比较[J].大理学院学报(综合版),2004,31(5):7-8. 被引量:21
  • 2崔青山,王志学,马海东.应用辛酸法-DEAE纤维素吸附过滤法提纯的IgG制备RIA用二抗[J].兽医大学学报,1993,13(2):133-135. 被引量:6
  • 3冷扬,刘铀,刘艳芬,王群,潘颖斌,高志杰.猪抵抗素(resistin)ELISA检测方法的建立[J].中国畜牧兽医,2007,34(6):58-60. 被引量:1
  • 4Major EO, Amemiya K, Tornatore CS,et al. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus - induced demyelinating disease of the human brain. Clin Microbiol, 1992, Rev 5:49 -73
  • 5Wei- Chih Ou,Meilin W,Chiung yau F,et al. The major capsid protein, VP1, of human JC virus expressed in Escherichia coli is able to self - assemble into a capsid - like particle and deliver exogenous DNA into human kidney ceils. Journal of General Virology. 1999,80:39 -46
  • 6Belnap DB, Olson NH, Cladel NM ,et al. Conserved features in papillomavirus and polyomavirus capsids. Journal of Molecular Biology,1996,259:249 - 263
  • 7Delbue S,Branchetti E ,Bertolacci S,et al. JC virus VP1 loop -specific polymorphisms are associated with favorable prognosis for progressive muhifocal lukoencephathy. J Neurovirol,2008,28 ( 11 ) : 1 - 6
  • 8Shamil RS,Lugovskoy A,Simon K, et al. Adaptive Mutations in the JC Virus Protein Capsid Are Associated with Progressive Muhifocal Leukoencephalopathy (PML). PLoS Genet,2009,5 (2) : e1000368
  • 9Kawano MA,Inoue T,Tsukamoto H, et al. The VP2/VP3 minor capsid protein of simian virus 40 promotes the in vitro assembly of the major capsid protein VP1 into particles. J Biol Chem, 2006,281 : 10164 - 10173
  • 10Kuroda MJ, Zheng Y. A prospective between JC virus - specific cytotoxic study demonstrates an association T lymphocytes and the early control of progressive muhifocal leukoencephalopathy. Brain,2004, 127 1970 - 1978

共引文献2

同被引文献12

  • 1朱珊丽,郑丹,欧琴,陈俊,陈韶,张丽芳.沙眼衣原体主要外膜蛋白T、B细胞多表位基因的表达及其鉴定[J].中华微生物学和免疫学杂志,2007,27(6):536-539. 被引量:4
  • 2Wallin KL,Wiklund F,Luostarinen T,et al.APopulation-basedProspective study of Chlamydia trachomatis infec-tion and cervical carcinoma[J].Int J Cancer,2002,101(4):371-374.
  • 3Tamim H,Finan RR,Sharida HE,et al.Cervicovaginal coinfections with humanPapillomavirus and Chlamydia trachomatis[J].Diagn Microbiol Infect Dis,2002,43(4):277-281.
  • 4KilmarxPH,MockPA,Levine WC.Effect of Chlamydia trachomatis coinfection on HIV shedding in genital tract secretions[J].Sex Transm Dis,2001,28(6):347-348.
  • 5Crane DD,Carlson JH,Fischer ER,et al.Chlamydia tracho-matisPolymorphic membraneProtein D is a species-com-monPan-neutralizing antigen[J].Proc Natl Acad Sci USA,2006,103(6):1894-1899.
  • 6Lampe MF,Wong KG,Kuehl LM,et al.Chlamydia tracho-matis major outer membraneProtein variants escape neu-tralization by both monoclonal antibodies and human im-mune sera[J].Infect Immun,1997,65(1):317-319.
  • 7Pal S,Peterson EM,Rappuoli R,et al.Immunization with the Chlamydia trachomatis major outer membraneProtein,using adjuvants developed for human vaccines,can inducePartialProtection in a mouse model against a genital chall-enge[J].Vaccine,2006,24(6):766-775.
  • 8Singh SR,Hulett K,Pillai SR,et al.Mucosal immunization with recombinant MOMP genetically linked With modified cholera toxin confersProtection against Chlamydia trachomatis infection[J].Vaccine,2006,24(8):1213-1224.
  • 9Sun G,Pal S,Weiland J,et al.Protection against an intrana-sal challenge by vaccines formulated with native and recom-binantPreparations of the Chlamydia trachomatis major outer membraneProtein[J].Vaccine,2009,27(36):5020-5025.
  • 10Su H,Caldwell HD.Immunogenicity of a chimericPeptide corresponding to T helper and B cell epitopes of the chlamy-dia trachomatis major outer membraneProtein[J].J Exp Med,1992,175(1):227-235.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部